Tryp Targets Patent In Bid To Battle Binge Eating Disorder With Psilocybin

Tryp’s Phase II Study of the Treatment of Overeating utilizing Psilocybin (STOP) trial in collaboration with the University of Florida, represents the first use of psilocybin in conjunction with psychotherapy as a therapeutic intervention in patients with BED.